Understanding basic concepts and strategies for obtaining pharmaceutical reimbursement

Area of Science:

• Health policy
• Pharmaceutical economics
• Healthcare administration

Background:

• Navigating pharmaceutical reimbursement policies is complex.
• Different patient settings have distinct billing requirements.
• Centers for Medicare & Medicaid Services (CMS) regulations impact drug reimbursement.

Purpose of the Study:

• To outline the rules governing pharmaceutical reimbursement.
• To detail strategies for obtaining reimbursement for various patient types.
• To clarify differences in reimbursement for hospital inpatients, outpatients, and those treated in physician-owned clinics.

Main Methods:

• Analysis of Centers for Medicare & Medicaid Services (CMS) guidelines.
• Review of claim form requirements.
• Examination of data elements necessary for reimbursement.

Main Results:

• Specific claim forms and data (patient location, drug, HCPCS code, status indicator, billing unit, revenue code, ICD-9 code) are mandatory for CMS pharmaceutical reimbursement.
• Reimbursement requirements differ between hospital inpatients and outpatients.
• Claims for physician-owned clinics are processed differently than hospital outpatient claims, though reimbursement rates are consistent.

Conclusions:

• Frequent changes in reimbursement rules pose a significant challenge.
• Thorough knowledge of rules and setting-specific requirements is essential for successful pharmaceutical reimbursement.